Urinary proteomics in kidney and cardiovascular disease

Saved in:
Bibliographic Details
Other Authors: Mischak, Harald (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2013.
Series:Henry Stewart talks. Biomedical & life sciences collection. Clinical proteomics.
Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease.
Subjects:
Online Access:https://hstalks.com/bs/2678/
Series (Clinical proteomics)
Series (Kidney in health and disease)
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000ngm a2200000 a 4500
001 HST3639
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 140117s2013 enk|||||||||||s|||v|eng d
028 5 0 |a 3639  |b Henry Stewart Talks 
035 |a (UkLoHST)2678 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Mischak, Harald,  |u (University of Glasgow, UK)  |4 spk  |9 104982 
245 1 0 |a Urinary proteomics in kidney and cardiovascular disease  |h [electronic resource] /  |c Harald Mischak. 
260 |a London :  |b Henry Stewart Talks,  |c 2013. 
300 |a 1 online resource (1 streaming video file (53 min.) :  |b color, sound). 
490 1 |a Clinical proteomics,  |x 2056-452X 
490 1 |a The kidney in health and disease,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Title from title frames. 
505 0 |a Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Biochemical markers.  |9 104983 
650 0 |a Cardiovascular system  |x Diseases.  |9 104984 
650 0 |a Kidneys  |x Diseases.  |9 104985 
650 0 |a Proteomics  |x Methodology.  |9 104986 
650 2 |a Biomarkers.  |9 104987 
650 2 |a Cardiovascular Diseases.  |9 104988 
650 2 |a Kidney Diseases.  |9 104989 
650 2 |a Proteome  |x analysis.  |9 104990 
650 2 |a Proteomics  |x methods.  |9 104991 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Clinical proteomics.  |9 104992 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Kidney in health and disease.  |9 104993 
856 4 0 |u https://hstalks.com/bs/2678/ 
856 4 2 |u https://hstalks.com/bs/p/751/  |3 Series (Clinical proteomics) 
856 4 2 |u https://hstalks.com/bs/p/980/  |3 Series (Kidney in health and disease) 
999 |c 215174  |d 215173